IBBQ Among Technology ETFs
End-of-day Nov 13, 2026 · 54 Technology ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.4% | −0.4% | +2.9% | +4.7% | +26.8% | +31.0% | +92.7% | +50.0% | +47.0% |
| Peer average | −1.2% | +2.0% | −7.3% | −10.1% | +6.1% | +4.9% | +72.6% | +26.1% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$89 of every $1,000 in IBBQ is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 8.91% | $891.44 | 69K | $11.7M |
| 2 | AMGNAmgen | Healthcare | 8.37% | $837.16 | 23K | $11.0M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.72% | $772.19 | 18K | $10.1M |
| 4 | MRNAModerna | Healthcare | 6.24% | $624.23 | 33K | $8.2M |
| 5 | REGNRegeneron Pharmaceuticals | Healthcare | 6.10% | $609.93 | 8,320 | $8.0M |
| 6 | RVMDRevolution Medicines | Healthcare | 2.44% | $243.52 | 18K | $3.2M |
| 7 | BIIBBiogen | Healthcare | 2.35% | $235.39 | 12K | $3.1M |
| 8 | ILMNIllumina | Healthcare | 2.02% | $202.32 | 12K | $2.6M |
| 9 | RPRXRoyalty Pharma | Healthcare | 1.96% | $196.07 | 37K | $2.6M |
| 10 | ROIVRoivant Sciences | Healthcare | 1.90% | $189.94 | 59K | $2.5M |
| 11 | ARGXArgenx SE | Healthcare | 1.67% | $167.32 | 2,240 | $2.2M |
| 12 | INSMInsmed | Healthcare | 1.66% | $165.64 | 18K | $2.2M |
| 13 | UTHRUnited Therapeutics | Healthcare | 1.61% | $160.85 | 3,534 | $2.1M |
| 14 | INCYIncyte | Healthcare | 1.56% | $155.96 | 17K | $2.0M |
| 15 | VTRSViatris | Healthcare | 1.52% | $152.05 | 94K | $2.0M |
of the $365B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 8.91% |
| 2 | AMGN | Amgen | 8.37% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.72% |
| 4 | MRNA | Moderna | 6.24% |
| 5 | REGN | Regeneron Pharmaceuticals | 6.10% |
| 6 | RVMD | Revolution Medicines | 2.44% |
| 7 | BIIB | Biogen | 2.35% |
| 8 | ILMN | Illumina | 2.02% |
| 9 | RPRX | Royalty Pharma | 1.96% |
| 10 | ROIV | Roivant Sciences | 1.90% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.23 |
| Jun 22, 2026 | Jun 26, 2026 | $0.0342 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0361 |
| Dec 22, 2025 | Dec 26, 2025 | $0.0906 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0958 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0287 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0402 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0619 |
| Sep 23, 2024 | Sep 27, 2024 | $0.0894 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0506 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0435 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0526 |